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Biliary tract obstructionAbstract Introduction: Percutaneous Transhepatic Biliary Drainage (PTBD) is a procedure
indicated in patients with non-operative lesions, when endoscopic application of prosthesis is
impossible due to anatomic reasons, complications or severe general condition of patient. Most
often it is a palliative procedure, aiming for live-quality improvement, although not altering
prognosis of basic disease.
Aim: This study presents own experience in biliary drainage with the aid of percutaneous transhep-
atic method and simultaneous assessment of method effectiveness and safety. The aim was to assess
outcomes and complications of PTBD in a large group of patients.
Materials and method: In time period 2007–2014, 167 patients hospitalized in Radiodiagnostics
and Radiology Department of Clinical Hospital, were investigated retrospectively. PTBD proce-
dure was applied to patients with biliary tract obstruction. In total 186 procedures of percutaneous
drainage were applied. Average age of patients was 63.6 years. Bilirubin, alkaline phosphatase and
gamma-glutamyl transferase were measured before and after procedure. All data were analyzed sta-
tistically.
Results: In examined group percutaneous drainage was successful in 90.7% interventions. In 8.1%
procedures drainage application was ineffective. The most common complication during procedure
was hemobilia (3.2%) and the long term complication was drain dislocation (2.7%). The mean
bilirubin levels declined from 397.06 lmol/l before drainage to 297.88 lmol/l after drainage
(p< 0.05).
Figure 1 A 67-year-old patient. Per
biliary tract. Fluoroscopy images dem
186 D. Knap et al.Conclusions: PTBD is an effective method of biliary tract decompression and it is an important
alternative to endoscopic drainage. This method is indicated in patients with neoplastic obstruction
of biliary tract with low expected survival rate and thus is a palliative procedure.
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by-nc-nd/4.0/).1. Introduction
Two main neoplasms causing obstructive jaundice are pancreas
carcinoma and cholangiocarcinoma. Other causes include gall
bladder carcinoma, hepatocellular carcinoma, metastases to
the liver and advanced carcinoma of stomach or duodenum.
Therapy of obstructive jaundice aims at restoring patency of
biliary ducts. Thanks to technical and instrumental develop-
ment of interventional radiology, decompression of biliary
ducts is possible [Fig. 1]. Percutaneous Transhepatic Biliary
Drainage (PTBD) is intended for patients with non-operative
lesions, when endoscopic stent application is impossible due
to anatomic reasons, complications or severe general state of
patient.1,2 In such patients PTBD plays an important role in
treatment. Drainage can normalize plasma bilirubin level3,4
and alleviate jaundice symptoms5, leading to improvement in
quality of life, thus optimizing the clinical state of patient allow-
ing for resection or palliative radio or chemotherapy. However,
the negative side of this method is a large number of early or
late complications as well as necessity of bile delivery to the
gastrointestinal tract.5,6 Complications include hemorrhage,
cholangitis, hemobilia, biliary duct perforation, peritonitis,
edema, sepsis, infection and neoplastic cells spreading among
biliary duct.7
Reduction in plasma bilirubin level is usually a signiﬁcant
marker of successful drainage. Nevertheless, in spite of proper
catheter positioning in the biliary duct, some patients have
poor bile drainage and a high plasma bilirubin level.8 PTBD
most often is a palliative procedure, aiming to improve a
patients’ quality of life, although not changing the prognosis
related to the basic condition.
This paper aims for the assessment of effectiveness and
complication numbers in patients with obstructive jaundice
treated by PTBD.cutaneous drainage of biliary du
onstrating distal CBD obstructi2. Materials and methods
The Department of Radiology of the Central Clinical Hospital
performed 186 procedures of Percutaneous Transhepatic
Biliary Drainage (PTBD) in the years spanning 2007–2011.
The clinical records of patients with obstructive jaundice from
the General Surgery Ward and Gastroenterology Ward were
analyzed. The study group consisted of 167 patients: 87
females (52%) and 80 males (48%). The average age of women
was 62 years and the average age of men was 62 years.
Population structure of the study [Fig. 2].
The main indications for PTBD include failed ERCP and
patients with conditions that do not qualify for ERCP.
Patients who qualiﬁed for PTBD were found to have dilated
intrahepatic ducts (right hepatic duct or left) of at least
5 mm, which was necessary for the insertion of the catheter
without damaging the duct walls. All patients were qualiﬁed
for the procedure on the basis of imaging tests including
ultrasonography, tomography and magnetic resonance imag-
ing. These tests revealed the presence of unresectable tumors
and biliary obstructions. All patients achieved histologic
conﬁrmation of the neoplastic nature of the change. In our
study, the three main unresectable tumors were pancreatic
head tumors (43.01%), cholangiocarcinoma (17.7%) and
metastases to the bile duct (10.75%) [Fig. 3]. The most
common location of biliary stricture was the common bile
duct (58.06%), common hepatic duct (33.97%) and left bile
duct (4.3%) [Fig. 4].
Signs and symptoms of biliary obstruction vary depending
on the disease process, history of prior intervention, and
comorbidities. In our case the most common sign and symp-
tom was clinical jaundice, which is common with a serum
bilirubin over 3 mg/dl. Additionally, to qualify for PTBD
patients’ INR had to be within normal limits.cts carried out on account of inoperable neoplasma inﬁltration of
on (A) and state of biliary tracts after decompression (B).
Figure 2 Population structure.
Biliary duct obstruction treatment 187Our patients were monitored carefully for 24 h after
drainage. In each case biochemical parameters’ control was
carried out.
2.1. Procedure evaluation
Patients abstained from oral intake or were on a clear liquid
diet for a minimum 4 h before the procedure. Biliary drainage
was performed using conscious sedation. Short-acting
benzodiazepines and narcotic agents were applied.
Approach to the right hemiliver was found from the 11th
intercostal space in the midaxillary line and on the left fromFigure 3 Causes of b
Figure 4 Location othree ﬁnger breadths below the xyphoid. When chosen, the site
for dermatotomy was anesthetized.
A needle was introduced through the liver into an intrahep-
atic bile duct to obtain a cholangiogram. Then the needle was
removed and another thinner needle with an overlying catheter
was inserted. After obtaining bile, the needle was withdrawn
but the catheter remained. Then a narrow guide wire was
introduced into the bile duct through the catheter.
After positioning the wire in one of the larger bile ducts, the
catheter was withdrawn and a Seldinger catheter was intro-
duced over the guide wire. Then the guide wire was withdrawn
and the Seldinger catheter was ﬁxed to the skin with a suture
[Fig. 5].
3. Results
3.1. Procedure outcomes
In the study group, 186 procedures of Percutaneous
Transhepatic Biliary Drainage (PTBD) were performed on
168 patients. The technical success (hepatic ducts cannulated
at the conclusion of the procedure) was achieved in 90.7% of
the procedures (n= 168). In 8.1% (n= 15), drainage applica-
tion was ineffective [Fig. 6]. Repeat procedures were required
in 24 (12.9%) patients [Fig. 7]. In treatment process, 22
patients needed two stages – repeating the PTBD procedure,
and the other 2 patients underwent interventions tree times.
Two cases (1.08%) withdrew from performing the procedures.
Of all the treatments, 179 (98.78%) procedures were per-
formed on extended bile ducts. In 4 cases, intervention was
carried out despite patients not having expanded bile tracts,iliary obstruction.
f biliary stricture.
Figure 5 A 69-year-old patient. Fluoroscopic images presenting following stages of placing the percutaneous transhepatic biliary drain.
Figure 6 Success of the procedure.
Figure 7 Repeat the procedure.
188 D. Knap et al.with two of them achieving technical success. Two others with-
drew from performing the procedure.
3.2. Patient outcomes
Laboratory tests were conducted before (last result immedi-
ately preceding drainage) and after PTBD in patients to assess
their general condition and the effectiveness of treatment.Laboratory tests included total bilirubin, alkaline phos-
phatase, and gamma-glutamyl transferase.
Serum bilirubin values were collected at baseline and during
follow-up. Elevated serum bilirubin was noted in 165 (98.31%)
of patients. The serum bilirubin level of three patients did not
exceed 17.1 lmol/l before the procedure. In 82.14% treat-
ments, decrease of bilirubin was achieved (p< 0.05). The
mean value of total bilirubin, presented before procedure of
PTBD was 397.06 lmol/l, with a range of 7.01–921.69 lmol/l.
The average declined level of bilirubin after percutaneous drai-
nage was to 297.88 lmol/l, with a range of 17.00–831.91 lmol/l
[Fig. 8].
The mean concentration of gamma-glutamyl transpeptidase
(GGTP) was found to be 638.49 IU/l, with a range of 57.00–
2704.00 IU/l. The decrease of GGTP was observed in
84.62% cases, to an average GGTP level to 396.79 IU/l (range
16.00–1716.00 IU/l) (p< 0.05) [Fig. 9].
Following biliary drainage there was a decrease of alkaline
phosphatase in 86.89%. The mean level of ALP before treat-
ment was 722.70 IU/l and was reduced after percutaneous bil-
iary drainage to an average to 481.35 IU/l (p< 0.05) [Fig. 10].
Percutaneous biliary decompression in the objective assess-
ment found regression of hyperbilirubinemia and reduction of
elevated values of GGT and ALP.
3.3. Complications
With proper technique, including peripheral bile duct punc-
ture, serious bleeding complications are uncommon. Since
the hepatic artery, portal vein, and bile duct travel side by side
within portal triads, it is not unusual for blood to enter the bile
duct during catheter ﬁxing, resulting in transient hemobilia.9 It
is not surprising that the most common complication stated in
the study group was hemobilia.
Any abnormality of a hepatic arterial branch adjacent to
the biliary drainage catheter should be taken as presumptive
evidence of injury to the branch. Despite prophylactic antibi-
otic coverage, sepsis may be seen immediately after drainage
or within several hours.10
Complications and adverse events occurred in 13.52%
(n= 25), documented in patient’s medical record 30 days fol-
lowing procedure. Complications occurred in eleven patients
(5.95%) immediately postprocedure (till 24 h). The most com-
mon complication during drainage was hemobilia (3.2%).
Immediately after the procedure hemobilia was observed in 7
patients – through a drain came out of the bloody content.
Perforation of bile ducts appeared in 3 patients (1.62%). One
Figure 8 Bilirubin level before and after PBTD [lmol/l].
Figure 9 GGTP level before and after PBTD [UI/l].
Biliary duct obstruction treatment 189patient, instantly during procedure had a dislocation of the
drain [Table 1].
Long-term complications of PTBD appeared in 7.57%
(n= 14). Of these 14 patients, 5 (2.70%) had drain disloca-
tion, 2 (1.08%) reported dysfunction of the drain and 2
(1.08%) had biliary tract hemorrhage to the peritoneal cavity
[Table 2].3.4. Survival
Mortality in the ﬁrst week postprocedure was 5.95% (n= 10).
In the second week after the treatment two deaths were
reported. One patient died within 4 weeks, and also one patient
died within 3 weeks of biliary drainage. Two deaths were
Figure 10 ALP level before and after PBTD [UI/l].
Table 1 Complications during the procedure [%].
Intrahepatic bile ducts perforation 0.54
Hemobilia 3.76
Extrahepatic bile ducts perforation 1.08
Total 5.38
Table 2 Complications after the procedure [%].
Drain dislocation 4.30
Hemobilia 1.61
Peritonitis 0.54
Sepsis 0.54
Fluid cumulation 0.54
Biliary ﬁstula 0.54
Total 8.06
190 D. Knap et al.directly related to PTBD (1 sepsis, 1 hemorrhage). The rest of
the deaths were caused by severe general condition and cancer
cachexia.
4. Discussion
PTBD is a second-line nonsurgical treatment for patients with
malignant biliary obstruction after ERCP failure despite the
higher risk of hemorrhage.11–13 The PTBD in our center was
successful in 90.86% of the cases. This conﬁrms numbers
reported in several studies.11The main indication for PTBD was pancreatic head tumor
(43%), before cholangiocarcinoma (17.7%). Literature points
out similar causes of jaundice.14,15 However, it is also impor-
tant to remember that metastasis to the porta hepatis from
many different tumors, can cause malignant biliary obstruc-
tion.16 Other indications, like HCC, were shown in different
studies.11
After successful PTBD, the total bilirubin level was
reduced.14,15,17,18 However, the TBIL levels of patients belong-
ing to the uninfected group were signiﬁcantly lower compared
to those from the infected group.19 In the current study, the
average value before the procedure amounted to 23.22 mg%
while postprocedure 17.42 mg%. Moreover, both levels of
PA and GGTP were reduced after PTBD. Comparable ﬁgures
were presented in another study14 where PA levels had been
also reduced.
In our case, the most common postprocedure complication
was drain dislocation, which also appeared in other stud-
ies.11,17 The low percentage of patients with postprocedure
hemobilia (1.61%) was conﬁrmed in several published stud-
ies.9,14,17,20 However, because of the anatomy of portal triads,
the procedure must be performed with suitable technique in
order to prevent severe bleeding. Moreover, PTBD should
not be performed on patients with nondilated bile ducts,
because of high risk of complications. The success rate of
PTBD for patients with dilated bile ducts is signiﬁcantly
greater.9,21
Despite prophylactic antibiotics coverage, sepsis can occur
right after drainage or within few hours after the procedure.10
In presented case, the number of sepsis and peritonitis reached
1.08%, although other studies show that these can be the most
common complications after PTBD.14,15,19
Biliary duct obstruction treatment 191Quality of living does not improve signiﬁcantly after
PTBD, because of high mortality rate in this population and
fast progression of the underlying disease.17 Nevertheless, the
deleterious effect of pruritus on quality of living can be elimi-
nated by drainage of the biliary ducts.14,17,20
Unfortunately, we were not able to examine the overall sur-
vival in our patients. Our numbers showed that 92.47% of
patients were discharged, while 7.53% of patients died. The
main cause of death was the primary tumor progression.
Teixeira et al. reported that the median survival period after
PTBD was 2.9 months.13 Many studies involving patients with
malignant biliary obstruction show similar values.2,12,22
Final conclusion
1. PTBD is an effective method of biliary tract decompression
and it is an important alternative to endoscopic drainage.
2. Percutaneous drainage of biliary ducts decompresses
mechanical jaundice and decreases typical serum markers
of cholestasis.
3. PTBD is indicated in patients with neoplastic obstruction
of biliary tract with low expected survival rate and thus is
a palliative procedure.
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